IV. Bisphosphonates promote healing of complicated stress fractures in the foot
Open Access
- 16 July 2021
- journal article
- Published by Peertechz Publications Private Limited in Open Journal of Orthopedics and Rheumatology
- Vol. 6 (1), 057-061
- https://doi.org/10.17352/ojor.000039
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- A case of atypical femoral fracture with abnormal cortical bone characterized by impaired mineralization and pyrophosphate accumulationBone Abstracts, 2013
- “Atypical femoral fractures” during bisphosphonate exposure in adult hypophosphatasiaJournal of Bone and Mineral Research, 2012
- Anticancer Properties of Zoledronic AcidCancer Investigation, 2010
- Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral ResearchJournal of Bone and Mineral Research, 2010
- Zoledronic Acid and Clinical Fractures and Mortality after Hip FractureThe New England Journal of Medicine, 2007
- Once-Yearly Zoledronic Acid for Treatment of Postmenopausal OsteoporosisThe New England Journal of Medicine, 2007
- Bisphosphonates: Mode of Action and PharmacologyPEDIATRICS, 2007
- A 2 yr longitudinal radiographic study examining the effect of a bisphosphonate (risedronate) upon subchondral bone loss in osteoarthritic knee patientsRheumatology, 2006
- Transient bone marrow edema syndrome progressing to avascular necrosis of the hip ? a case report and review of the literatureClinical Rheumatology, 2004
- Stress FracturesSports Medicine, 1996